Law360 - The Newswire for Business Lawyers
Sign In
 

Try our Advanced Search for more refined results

Law360
  • Search Law360
  • Search News Only
  • Search Cases Only
  • Search PTAB Only
  • Search TTAB Only
  • Advanced Search
  Sign In

Law360

|

The Practice of Law

Access to Justice Aerospace & Defense Appellate Asset Management Banking Bankruptcy Benefits California Cannabis Capital Markets Class Action Colorado Commercial Contracts Competition Compliance Connecticut Construction Consumer Protection Corporate Criminal Practice Cybersecurity & Privacy Delaware Employment
Energy Environmental Fintech Florida Food & Beverage Georgia Government Contracts Health Hospitality Illinois Immigration Insurance Intellectual Property International Arbitration International Trade Legal Ethics Legal Industry Life Sciences Massachusetts Media & Entertainment Mergers & Acquisitions Michigan Native American
New Jersey New York North Carolina Ohio Pennsylvania Personal Injury & Medical Malpractice Private Equity Product Liability Project Finance Public Policy Real Estate Retail & E-Commerce Securities Sports & Betting Tax Technology Telecommunications Texas Transportation Trials Washington White Collar

Law360 Pulse

|

Business of Law

California Pulse Connecticut Pulse Courts DC Pulse Daily Litigation Delaware Pulse
Florida Pulse Georgia Pulse In-House Insights Legal Tech Mid-Law
Modern Lawyer New Jersey Pulse New York Pulse Pennsylvania Pulse Small Law Texas Pulse

Law360 Authority

|

Deep News & Analysis

Tax Authority

Federal International State & Local

Employment Authority

Discrimination Labor Other Wage & Hour

Insurance Authority

General Liability Other Property Specialty Lines

Real Estate Authority

Commercial Other Residential

Bankruptcy Authority

Large Cap Mid Cap

Healthcare Authority

Deals & Corporate Governance Digital Health & Technology Other Policy & Compliance

Global

Law360 UK

Commercial Litigation UK Corporate Crime & Compliance UK Employment UK Financial Services UK Insurance UK Intellectual Property UK Pulse UK Transactions UK
Close
  • Law360
  • Law360 UK
  • Law360 Pulse
  • Law360 Employment Authority
  • Law360 Tax Authority
  • Law360 Insurance Authority
  • Law360 Real Estate Authority
  • Law360 Healthcare Authority
  • Law360 Bankruptcy Authority
  • Products
  • Lexis®
  • Law360 Tax Authority
  • Law360 In-Depth
  • Law360 Podcasts
  • Rankings
  • Leaderboard Analytics
  • Regional Powerhouses
  • Law360's MVPs
  • Women in Law Report
  • Law360 400
  • Diversity Snapshot
  • Practice Groups of the Year
  • Rising Stars
  • Titans of the Plaintiffs Bar
  • Sections
  • Adv. Search & Platform Tools
  • About all sections
  • Browse all sections
  • Banking
  • Bankruptcy
  • Class Action
  • Competition
  • Employment
  • Energy
  • Expert Analysis
  • Insurance
  • Intellectual Property
  • Product Liability
  • Securities
  • Beta Tools
  • Track docs
  • Track attorneys
  • Track judges
  • Site Menu
  • Join the Law360 team
  • Search legal jobs
  • Learn more about Law360
  • Read testimonials
  • Contact Law360
  • Sign up for our newsletters
  • Law360 Company
  • About Law360 Authority
  • Resource Library
  • Site Map
  • Help
CaseMap® CLE On-Demand Context CourtLink® Digital Library Intelligize Law360 Lex Machina Lexis Medical Navigator™ Lexis® Lexis+™
Lexis® Tax MLex® Nexis® Nexis Diligence™ Nexis Newsdesk™ Practical Guidance Product Liability Navigator Securities Mosaic® State Net® Verdict & Settlement Analyzer
Intellectual Property Securities Bankruptcy Competition Employment White Collar Legal Industry Access To Justice Law360 UK Pulse || See all sections ||
 
 
 

Search within the list below:

Name Count

Please assign a name to this alert

  • News & Analysis (56)
  • Cases
  • PTAB Cases
  • TTAB Cases

News (56)

  1. November 06, 2024 | Pulse Exclusive AN2 Therapeutics Elevates Top Atty To CLO, COO

    ...Pharmaceuticals PLC and nearly four years with Actelion Pharmaceuticals as senior counsel and later...

  2. September 19, 2024 | Pulse Exclusive Ideaya Biosciences Names Pharma, Biotech Vet As GC

    ...During that time, Jazz Pharmaceuticals PLC paid $7.2 billion to acquire GW Pharmaceuticals PLC....

  3. July 23, 2024 4 Firms Guide SPAC Mergers Targeting AI, Cannabis Sectors

    ...Phytanix founders Colin Stott and Dominic Schiller, both former executives at GW Pharmaceuticals Ltd....

  4. March 07, 2024 | Pulse Exclusive Top BioNTech Atty Will Add Chief Business Officer Role

    ...In November 2014, Ryan moved in-house as head of legal affairs for GW Pharmaceuticals PLC before joining...

  5. December 07, 2023 Investment Co. Seeks Sanctions In Pot Real Estate Row

    ...Pharmaceuticals, but nothing like that ever came to fruition....

  6. September 08, 2023 Landlord Countersues Pot Co. For Violating Rent Settlement

    ...Pharmaceuticals, but nothing like that ever came to fruition....

  7. August 14, 2023 | Pulse Exclusive BioNTech Promotes GC To Chief Legal Officer

    ...Pharmaceuticals PLC....

  8. July 18, 2023 CBD Co. Wants Counterclaims Nixed In Epidiolex Patent Row

    ...British pharmaceutical firm GW Pharmaceuticals has urged a New Jersey federal judge to toss counterclaims...

  9. April 24, 2023 Fed. Circ. Backs UK Pharma Firm's IP Win Against CBD Giant

    ...GW Pharmaceuticals PLC, case number 22-1603, in the U.S....

  10. March 21, 2023 GW Pharma Investors Ink $7.75M Deal In Suit Over Jazz Sale

    ...GW Pharmaceuticals is represented by Noah A....

  11. February 02, 2023 IP Forecast: Fed. Circ. To Eye Cooley's Conduct In CBD Row

    ...Pharmaceuticals....

  12. January 05, 2023 CBD Drug Co. Alleges Teva, Others Violated Patents

    ...British pharmaceutical firm GW Pharmaceuticals has accused a dozen drug manufacturers, including Teva...

  13. November 08, 2022 Drugmaker Loses Fight To Get Seizure Drug Suit Thrown Out

    ...GW Pharmaceuticals was acquired in May by Ireland-based Jazz Pharmaceuticals PLC....

  14. August 16, 2022 Fed. Circ. Urged To Toss Pot Co.'s CBD Patent Appeal

    ...GW Pharmaceuticals PLC, case number 22-1603, in the U.S....

  15. August 02, 2022 Canopy Growth Hires Cannabis Industry Vet As Top Atty

    ...Gedeon joins Canopy while the company is litigating a patent infringement fight against units of GW Pharmaceuticals...

  16. July 01, 2022 Pot Co. Canopy Takes CBD Patent Row To Fed. Circ.

    ...GW Pharmaceuticals PLC, case number 22-1603, in the U.S....

  17. June 06, 2022 GW Pharma Wants Judge To Nix Investor Suit Over $7.2B Deal

    ...GW Pharmaceuticals is represented by Noah A....

  18. May 30, 2022 | UK Exclusive Drugmaker Fights Japanese Rival's Unpaid Royalties Suit

    ...Otsuka sued GW Pharma and its subsidiary, GW Pharmaceuticals Ltd., in October....

  19. May 25, 2022 Cannabis Co. Sues Business Partner Over Lost License

    ...resulting from this deal would allow the company to become a major pharmaceutical company, akin to GW...

  20. May 23, 2022 | UK Exclusive Drugmaker Can't Pause Royalty Suit Amid Appeal

    ...GW Pharmaceuticals was acquired in May by Ireland-based Jazz Pharmaceuticals PLC....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Archive of over 450,000 articles
  • Database of over 2.1 million cases
  • Full-text search of patent complaints
  • Full-text search of PTAB cases and documents
  • Database of TTAB cases and documents, including full-text search of documents
  • Customized email alerts and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View full search results

Already a subscriber? Click here to login

Already have access? Click here to login

Get instant access to the one-stop news source for business lawyers

Register Now!

Sign up now for free access to this content

PLEASE NOTE: A verification email will be sent to your address before you can access your trial.

Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.

You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.

We take your privacy seriously. Please see our Privacy Policy.

Register

Already have access?

  1. Forgot your password?
  2. Sign In
RELX Group Lexis Nexis

© 2025, Portfolio Media, Inc. | About | Contact Us | Advertise with Law360 | Careers at Law360 | Terms | Privacy Policy | Cookie Settings | Processing Notice | Ad Choices | Help | Site Map | Resource Library | Law360 Company | Testimonials